FindTrial
Sign In

Value of AFP and ChE in predicting clinical outcome of liver failure

Value of AFP and ChE in predicting clinical outcome of liver failure

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800015284
Enrollment
Unknown
Registered
2018-03-20
Start date
2018-05-01
Completion date
Unknown
Last updated
2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver failure

Interventions

Live group:Serological examination
Death group:Serological examination

Sponsors

Shangqiu First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: In line with the liver failure patients diagnosed and treated by the Chinese Medical Association in 2012 revised by the Chinese Medical Association

Exclusion criteria

Exclusion criteria: 1. Age 75 years old; 2. with liver cancer; 3. other systems or organs of benign and malignant tumors; 4. severe cardiovascular, cerebrovascular, renal, hematopoietic system primary disease; 5. mental system primary disease; 6. pregnant, lactating women; 7. incomplete data.

Design outcomes

Primary

MeasureTime frame
AFP;ChE;—

Countries

China

Contacts

Public ContactShao Qiguo

Shangqiu First People's Hospital

shaoqiguoshangqiu@163.com+86 18930398279

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026